USPTO serial 98090005
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Songpa-gu, Seoul, KR
Songpa-gu, Seoul, KR
Songpa-gu, Seoul, KR
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alan Taboada
Alan Taboada MOSER TABOADA1040 Broad Street - Suite 103SHREWSBURY, NJ 07702United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Enzymes for scientific or research purposes; Reagents for scientific or medical research use; Monoclonal antibodies for scientific purposes; Chemical preparations in the nature of markers for analyzing proteins for scientific or laboratory purposes; Reagents for analyzing proteins for scientific and research use; Biological preparations for scientific or laboratory use, namely, protein preparations made from human blood, blood plasma or blood serum; Biological preparations for scientific or laboratory purposes; Recombinant protein arrays for scientific research; Chemical preparations for scientific purposes; Enzyme for scientific and research purposes; Diagnostic preparations for scientific or research use; Biochemical preparations for scientific purposes; Reagents for scientific purposes; Diagnostic reagents for scientific use; Diagnostic preparations for scientific use; In vitro diagnostic reagents for scientific purposes; Antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; Antibody reagents for scientific purposes; Serum samples for scientific purposes; Chemical reagents for scientific purposes; Chemical preparations for scientific purposes; Chemical preparations for scientific purposes, other than for medical or veterinary use; Enzyme substrates for scientific purposes; Chromatography chemicals; Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biological preparations for use in the biotechnology industry; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Chemical preparations for analyses in laboratories, other than for medical purposes; Reagents for medical research; Diagnostic reagents, other than for medical or veterinary purposes; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations for scientific or research use, other than for medical or veterinary use; Reagents for chemical analyses, other than for medical or veterinary purposes; Chemical reagents, other than for medical or veterinary purpose; Chemical reagents, other than for medical or veterinary purposes; Reagents for use in scientific apparatus for chemical or biological analysis; Reagent paper for inspection, other than for medical or veterinary purposes; Reagent paper, other than for medical or veterinary purposes; Chemically treated non-medical test strips for calibration of laboratory test equipment | ACTIVE | — |
| 005 | Reagents for analytical purposes in the nature of diagnostic reagents for medical use; Chemical reactants for veterinary purposes; Reagents for use in analysis in the nature of diagnostic reagents for medical use; Reagents for use with analyzers in the nature of diagnostic reagents for medical use; Biological reagents for veterinary use; Biological preparations for veterinary use in the treatment of cancer; Biochemical preparations for veterinary use in the treatment of cancer; Diagnostic reagents for medical use; Diagnostic reagents for veterinary use; Diagnostic test reagents for veterinary purposes; Diagnostic preparations for veterinary purposes; Reagents for in-vitro laboratory use for medical diagnostic purposes; Chemical reagents for veterinary purposes; Chemical test reagents for veterinary purposes; Chemical preparations for treating wounds for veterinary purposes; Enzymes for veterinary purposes; Enzyme preparations for veterinary purposes; Biological and chemical reagents for medical or veterinary purposes; Diagnostic test reagents for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Chemical reagents for analytical purposes; Biological preparations for the treatment of cancer for medical or veterinary purposes; Biochemical preparations for the treatment of cancer for medical or veterinary purposes; Diagnostic chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Chemical preparations for the diagnosis of pregnancy for medical or veterinary purposes; Immunoassay reagents for medical use; Reagents and media for medical and veterinary diagnostic purposes; Diagnostic preparations for medical and veterinary use; Chemical reagents for medical or veterinary purposes; Diagnostic reagents for use in analysis for medical and veterinary purposes; Diagnostic reagents for use with analyzers for medical and veterinary purposes; Biological reagents for medical purposes; Biochemical preparations for the diagnosis of cancer for medical use; Biochemical preparations for the diagnosis of cancer for medical purposes; Reagents for medical use; Reagents for use in diagnostic tests for medical purposes; Diagnostic reagents for medicinal use; Diagnostic reagents for medical use; Diagnostic reagents for medical purposes; Diagnostic test reagents for medical purposes; Diagnostic preparations for medical purposes; Diagnostic agents for medical use; Diagnostic chemical reagents for medical use; Chemical diagnostic reagents for medical use; Reagents for in-vitro laboratory use; In-vitro diagnostic preparations for medical purposes; Chemical preparations for testing blood for medical purposes; Chemical reagents for medical purposes; Diagnostic chemical test reagents for veterinary purposes; Diagnostic reagents for medical or veterinary purposes; Clinical medical reagents; Diagnostic biomarker reagents for medical purposes; Medical diagnostic test strips for breast milk analysis | ACTIVE | — |
| 009 | Diagnostic chips for inspecting blood plasma, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; Medical equipment, namely, apparatus for bioanalysis of proteins in the nature of reagent cartridges for sample preparation; Laboratory instruments, namely, homogenizers; Optical inspection apparatus; Apparatus for analyzing biological data for laboratory use, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Apparatus for inspecting biochips for laboratory use; Apparatus for analyzing biochips for laboratory use; Reagent analyzing apparatus for laboratory use for measuring, testing and analyzing blood and other bodily fluids; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Optical apparatus and instruments except for glasses and photographic apparatus; Optical apparatus for use in research and laboratory settings, namely, near infrared optical measurement apparatus for measuring brain functions and responses; Luminescence measuring devices, namely, luminometer to measure the amount of light produced; Downloadable computer software for diagnosing diseases for medical purposes | ACTIVE | — |
| 010 | Medical instruments, namely, biosensors for detecting infectious diseases; Apparatus in the nature of probes and buffers for use in measuring glycated hemoglobin; Diagnostic test kits consisting primarily of probes, buffers reagents for use in the detection of haemoglobin in faeces; Immunological analysers, namely, analyte testing devices; Medical diagnostic apparatus for testing for viruses; Home virus test kits comprised of medical instruments, namely, lancets and saliva collection devices for medical purposes for taking biological samples for review and testing for various medical and genetic conditions; Bacteria and virus testing apparatus for medical purposes; Urine testing apparatus with color comparison chart for medical purposes; Medical diagnostic apparatus for veterinary purposes for testing for viruses; Medical diagnostic apparatus for the diagnosis of cardiovascular diseases; Medical measuring instruments for measuring blood count for cancer diagnosis; Medical instruments for measuring immunoassays in oral fluid for drug abuse testing; Medical apparatus for the diagnosis of inflammatory diseases; Medical and veterinary apparatus and instruments, namely, ophthalmoscopes; Measuring instruments adapted for medical use for measuring psychometrics; Test equipment for medical use, namely, pregnancy testing machines and apparatus; Medical immunoassay apparatus, namely, immunochemical testing apparatus for medical use; Medical diagnostic testing instruments for use in immunoassay procedure, namely analyte testing devices; Immunofluorescence analysis apparatus for medical purposes being immunoassay analyzers for medical diagnosis; Apparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of body fluids; Telemetry apparatus for medical purposes; Body fluid apparatus for carrying out diagnostic tests for medical purposes; Medical diagnostic apparatus and instruments for diagnosing cancer; Medical diagnostic apparatus and instruments for medical purposes for diagnosing cancer; Diagnostic measuring apparatus for medical use, namely, apparatus for measuring glucose levels; Measuring devices for medical use, namely, devices for measuring bloodwork metrics; Immunoassay cartridges for medical purposes, namely, medical diagnostic instruments for in vitro diagnosis of body fluids; Genetic testing apparatus for medical purposes; Apparatus for blood tests for medical use; Apparatus for blood monitoring for medical use; Medical apparatus and instruments in the fields of clinical diagnosis, namely, instruments for monitoring blood oxygen saturation, blood gas concentration, and vital signs; Medical diagnostic, examination, and monitoring equipment for ophthalmologic use; Immunoassay apparatus for medical diagnosis, namely, for diagnosing neurodegenerative diseases; Urine testing instruments for medical diagnostic purposes being urethral catheters; Automatic analyzers for medical diagnosis, namely, analyzers for bacterial identification for medical purposes; Medical diagnostic apparatus for medical purposes being a diagnostic apparatus for the detection of cancer; Urine analysis devices for medical diagnosis, namely, fluorescence immunoassay analyzer for analyzing the protein in urine; Clinical-chemical auto analysis apparatus for medical diagnosis, namely, cell counter, live cell imager and fluorescence immunoassay analyzer; Blood analysis apparatus for diagnosis; In vitro diagnostic devices for medical purposes, namely, incubators used for in vitro fertilization purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 15, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 27, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 27, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 21, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 14, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 25, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 25, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 25, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 13, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 13, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 13, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 24, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 24, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 24, 2024 | ALIE | ASSIGNED TO LIE | — |
| May 17, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 21, 2023 | NWAP | NEW APPLICATION ENTERED | — |